Coronavirus Updates

On October 5th, 2021 the Board of Health agreed that the current surge Covid-19 cases driven by variants and community spread is posing a growing immediate threat to the public health, safety, and welfare of people residing and working within the Town of Orange. In response to the rise in local case counts the Orange Board of Health voted on and passed the following motion: The Orange Board of Health is supporting the temporary closure of Town Buildings to the public, requiring masks to be used at all indoor businesses used by staff and customers, strongly reccomending that all employeres urge their employees to get vaccinated, and strongly urging all unvaccinated residents to get vaccinated. 


Important Coronavirus Vaccine Information:     

On October 20, 2021 the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:

  • The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
    • 65 years of age and older
    • 18 through 64 years of age at high risk of severe COVID-19
    • 18 through 64 years of age with frequent institutional or occupational exposure toSARS-CoV-2
  • The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.
  • The use of each of the available COVID-19 vaccines as a heterologous (or “mix and match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.
  • To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.

For more information please visit the FDA Press Release Here.


On September 22, 2021 the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in:

  • individuals 65 years of age and older;
  • individuals 18 through 64 years of age at high risk of severe COVID-19; and 
  • individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.

This updated emergency authorization applies only to the Pfizer-BioNTech COVID-19 Vaccine. For more information please visit the FDA Press Announcement Here


On August 23, 2021 the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.   For more information please visit the FDA Website.


At this time the Orange Board of Health is not holding any vaccination clinics.  We are still doing updates which are listed on this page as well as our Facebook page. We will update the public with any relevant Coronavirus information as needed. 

For more information on the coronavirus, visit the Massachusetts Website for Coronavirus Information or the Board of Health Facebook Page 

Feed